Cargando…

Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience

Detalles Bibliográficos
Autores principales: Guo, Tian-Jiao, Huang, Xiao-Jun, Wen, Lei, Lu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282684/
https://www.ncbi.nlm.nih.gov/pubmed/28091419
http://dx.doi.org/10.4103/0366-6999.198017
_version_ 1782503371309056000
author Guo, Tian-Jiao
Huang, Xiao-Jun
Wen, Lei
Lu, Jin
author_facet Guo, Tian-Jiao
Huang, Xiao-Jun
Wen, Lei
Lu, Jin
author_sort Guo, Tian-Jiao
collection PubMed
description
format Online
Article
Text
id pubmed-5282684
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-52826842017-02-17 Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience Guo, Tian-Jiao Huang, Xiao-Jun Wen, Lei Lu, Jin Chin Med J (Engl) Clinical Practice Medknow Publications & Media Pvt Ltd 2017-01-20 /pmc/articles/PMC5282684/ /pubmed/28091419 http://dx.doi.org/10.4103/0366-6999.198017 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Clinical Practice
Guo, Tian-Jiao
Huang, Xiao-Jun
Wen, Lei
Lu, Jin
Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
title Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
title_full Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
title_fullStr Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
title_full_unstemmed Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
title_short Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
title_sort two secondary primary malignancies after bortezomib therapy for multiple myeloma: a single-center experience
topic Clinical Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282684/
https://www.ncbi.nlm.nih.gov/pubmed/28091419
http://dx.doi.org/10.4103/0366-6999.198017
work_keys_str_mv AT guotianjiao twosecondaryprimarymalignanciesafterbortezomibtherapyformultiplemyelomaasinglecenterexperience
AT huangxiaojun twosecondaryprimarymalignanciesafterbortezomibtherapyformultiplemyelomaasinglecenterexperience
AT wenlei twosecondaryprimarymalignanciesafterbortezomibtherapyformultiplemyelomaasinglecenterexperience
AT lujin twosecondaryprimarymalignanciesafterbortezomibtherapyformultiplemyelomaasinglecenterexperience